Xilio Therapeutics XLO
NASDAQ XLO
$8.47 -0.06 (-0.70%)
At close: Nov 11, 2026 · 4:00 PM EST

Xilio Therapeutics (XLO) Capital Expenditures (2020 - 2026)

Updated

Analysis

Xilio Therapeutics (XLO) Capital Expenditures (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Xilio Therapeutics 167.94 Mn -378.15 Mn - -1.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -1.21 Mn
Jun 30, 2026 19,000.00
Mar 31, 2026 556,000.00
Dec 31, 2025 95,000.00
Jun 30, 2025 401,000.00
Mar 31, 2025 22,000.00
Dec 31, 2024 6,000.00
Sep 30, 2024 9,000.00
Jun 30, 2023 316,000.00
Mar 31, 2023 170,000.00
Dec 31, 2022 509,000.00
Sep 30, 2022 333,000.00
Jun 30, 2022 771,000.00
Mar 31, 2022 254,000.00
Dec 31, 2021 378,000.00
Sep 30, 2021 114,000.00
Jun 30, 2021 438,000.00
Mar 31, 2021 170,000.00
Dec 31, 2020 108,000.00
API Access

Xilio Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=XLO&period=max&api_key=YOUR_API_KEY